News

The Biochemistry and Molecular Biology Department recently held a poster session, during which students from Bryn Mawr, Haverford, and Swarthmore presented their research findings. Among the ...
Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed ...
A common mineral, α-alumina, found abundantly in Earth's crust, may have played a critical role in initiating the chemical reactions necessary for life to begin. This exciting discovery, detailed ...
We are proud to welcome Hada Fongha Leong, Ph.D., for a seminar titled: “Pain Unraveled: Bridging Biochemistry, Medicine, and Innovation.” This discussion aims to bridge the gap between biochemistry, ...
AYER KUNING POLLS | Perikatan Nasional's candidate for the Ayer Kuning by-election appears to be taking a jovial stance against claims accusing him of using a BN member's image in campaign ...
FIFA has unveiled its official host city posters for the men's 2026 World Cup-- due to take place across the United States, Canada and Mexico next summer -- and it's an eye-catching collection ...
However, the official Season 3 poster, which featured Carrie walking with friends Miranda (Cynthia Nixon), Charlotte (Kristin Davis), Seema (Sarita Choudhury), and Lisa (Nicole Ari Parker ...
Apr. 15, 2025 — Researchers have demonstrated a way to use corn protein to improve the performance of lithium-sulfur batteries, a finding that holds promise for expanding the use of the high ...
In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market ...
Rahway, New Jersey-based Merck & Co., Inc. (MRK) functions as a healthcare company. Valued at $200 billion by market cap, the company delivers health solutions through its prescription medicines ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...
Germany's Merck KGaA has said it needs to double the productivity of its R&D operations, with the aim of launching a new product every 18 months on average, to boost its pharma business.